Organogenesis Holdings (ORGO) Net Margin (2017 - 2026)

Organogenesis Holdings' Net Margin history runs 10 years deep, the most recent figure standing at 150.85% for Q1 2026.

• In Q1 2026, Net Margin fell 12595.0% year-over-year to 150.85%; the TTM figure through Mar 2026 stood at 2.54% (up 191.0% YoY), while the FY2025 annual figure was 4.55%, up 474.0% from the prior year.
• Net Margin was 150.85% for Q1 2026 at Organogenesis Holdings, down from 18.07% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 18.07% in Q4 2025 to a low of 150.85% in Q1 2026.
• Historically, Net Margin has averaged 8.4% across 5 years, with a median of 0.18% in 2022.
• The sharpest annual moves came in 2025 and 2026: Net Margin surged 1343 bps in 2025, then slumped 12595 bps in 2026.
• A 5-year view of Net Margin shows it stood at 6.48% in 2022, then sank by 109 bps to 0.57% in 2023, then soared by 914 bps to 4.64% in 2024, then soared by 290 bps to 18.07% in 2025, then sank by 935 bps to 150.85% in 2026.
• The last three Net Margin figures came in at 150.85% (Q1 2026), 18.07% (Q4 2025), and 9.63% (Q3 2025), per Business Quant data.